Ultrahuman
World's lightest smart ring tracking metabolic health and sleep.
💼 What does it do?
Ultrahuman creates an ecosystem of health-tracking devices that provide real-time insights into metabolic health. Their flagship Ring AIR is the world's lightest smart ring (2.4g) that monitors sleep, heart rate variability, movement, and temperature without subscription fees. They also offer the M1 continuous glucose monitor for real-time metabolism tracking, Ultrahuman Home for environmental health monitoring, and Blood Vision for preventive blood testing with their proprietary UltraTrace technology. The platform correlates data across multiple biomarkers to give users actionable health insights.
🧑🚀 About the founder(s)
ABOUT THEM
Mohit Kumar (CEO): Second-time entrepreneur who co-founded RoadRunnr (acquired by Zomato). Former COO of Food Delivery at Zomato where he scaled operations from thousands to millions of daily deliveries. IIT Delhi computer science graduate and martial arts enthusiast who discovered the power of biomarker tracking during training in Thailand.
Vatsal Singhal (Co-founder): Co-founded RoadRunnr with Mohit and led product/engineering at Zomato post-acquisition. CrossFit enthusiast with deep technical expertise in building scalable platforms. Known for his systematic approach to product development and data-driven decision making.
THE BACKSTORY
Two IIT friends who built and sold their first company (RoadRunnr) to Zomato, then helped scale Zomato's delivery business. After their Zomato stint, Mohit took a break to train martial arts in Thailand where he observed athletes using glucose meters despite not being diabetic. This sparked the insight that metabolic health exists on a spectrum and led to the idea of democratizing biomarker tracking for everyone. Meanwhile, Vatsal was exploring CrossFit and similar health optimization techniques. They realized the future of health would be preventive, data-driven, and integrated across multiple biomarkers.
📊 Pricing and business model
Hardware sales with no subscription fees for core features. Revenue primarily from:
• Ring AIR sales ($349 per unit)
• M1 glucose monitor subscriptions ($299/month)
• Blood Vision testing services
• Retail partnerships and international expansion
Focus on premium positioning with luxury variants in 18K gold and platinum
🚀 About this space
THE PROBLEM
Traditional health tracking is fragmented and reactive rather than preventive. Most wearables focus on basic fitness metrics without diving into metabolic health - the foundation of overall wellness. Athletes and health-conscious individuals struggle to get a comprehensive view of how sleep, nutrition, stress, and activity truly impact their bodies. Existing solutions are either too expensive, require multiple subscriptions, or provide data without actionable insights.
THE OPPORTUNITY
$750B+ global health and wellness market with growing demand for preventive healthcare. The smart ring category is nascent but rapidly expanding, with most players focused on basic metrics rather than comprehensive metabolic health. Ultrahuman's integrated approach positions them to capture market share from both traditional fitness wearables and medical device companies as consumers shift toward proactive health management.
ℹ️ Growthbuddy insights
INSIGHT #1
Hardware-software integration mastery: Unlike competitors who outsource manufacturing, Ultrahuman built their own 'UltraFactory' facilities in India and Texas. This gives them unprecedented control over quality, costs, and innovation speed. They iterate hardware at the speed of software - a massive competitive advantage in a space where most players rely on third-party manufacturers.
INSIGHT #2
Metabolic health timing advantage: While most wearables chase fitness metrics, Ultrahuman focused on metabolic health just as continuous glucose monitors became accessible to non-diabetics. Their clinical research published in Nature Scientific Reports validates their 'Metabolic Score' and positions them as a category leader in preventive health rather than reactive fitness tracking.
INSIGHT #3
Retail strategy differentiation: While competitors like Oura and Whoop rely on D2C online sales, Ultrahuman cracked the luxury retail code with presence in Selfridges London, Changi Airport, and Virgin Megastores. This premium positioning justifies higher prices and creates brand perception as a lifestyle accessory rather than just a health device.
💛 Their culture
• Execution-obsessed with a 'cross-functional learning' philosophy where software engineers learn sensor technology and marketers understand bioengineering.
• Founders are deeply involved - they respond to customer emails within 10 minutes and are 'always on' in their community channels.
• Strong emphasis on wealth creation for all employees, not just founders.
• Fast-paced environment that ships firmware updates every two weeks and app improvements weekly.
• Values long-term thinking over short-term gains, evidenced by their willingness to invest in manufacturing infrastructure while profitable.
ℹ️ Career intel
GREEN FLAGS
• Profitable at company level while investing in growth infrastructure
• Second-time successful founders with proven execution track record
• Differentiated product strategy focusing on metabolic health vs basic fitness
• Strong patent portfolio and published clinical research
• Manufacturing ownership providing competitive moats
• Premium retail partnerships creating brand elevation
• International expansion with US manufacturing facility
• No subscription dependency unlike competitors
POTENTIAL CONCERNS
• Rapid growth phase with potential scaling challenges
• Competition intensifying as Apple, Samsung enter smart ring space
• Regulatory risks in health device space
• Manufacturing complexity across multiple geographies
• High customer acquisition costs in premium segment
• Patent litigation ongoing with Oura Ring
• Dependence on glucose monitor subscription revenue
WHY NOW
Ultrahuman sits at the intersection of multiple mega-trends: preventive healthcare, wearable tech miniaturization, and metabolic health awareness. They've achieved the rare combination of profitability with hypergrowth, giving them runway to execute without funding pressure. The potential $120M round at 4x+ valuation indicates serious momentum. Joining now means ground-floor opportunity in a category-defining company before they become the next Indian unicorn.
📝 Interview guidance
Demonstrate understanding of:
• Difference between metabolic health and basic fitness tracking
• Challenges of hardware-software integration at scale
• Why manufacturing ownership matters in wearables
• Preventive vs reactive healthcare approaches
Questions to ask:
• How do you maintain innovation speed while scaling manufacturing?
• What's the long-term vision for the metabolic health platform?
• How do you see competition evolving as big tech enters smart rings?
• What role does clinical research play in product development?
⚡️ Fast facts
FUNDING
$65M total across multiple rounds:
• $7.5M seed (2020) from Nexus Venture Partners and Blume Ventures
• $17.5M Series A (2022) led by Alpha Wave Incubation
• $35M Series B (2024) led by Blume Ventures
Currently in talks for $120M+ round at $550-600M valuation
INVESTORS
Blume Ventures, Nexus Venture Partners, Alpha Wave Incubation, Steadview Capital, Deepinder Goyal (Zomato), Kunal Shah (CRED), Nithin Kamath (Zerodha), Balaji Srinivasan (ex-Coinbase), RazorPay founders, and others
THE NUMBERS
• Second-largest smart ring maker globally
• $150M annualized revenue run rate (2025)
• Manufacturing capacity: 500,000+ units annually
• Profitable at company level
• 150+ retail outlets worldwide
• Patent portfolio with 20+ filed patents
• Clinical trials with 105+ participants published in Nature Scientific Reports
🔎 Overview
WEBSITE
FOUNDING YEAR
2019
INDUSTRY TAGS
B2B, Healthcare, SaaS
HEADQUARTERS
Bengaluru, India (with manufacturing facilities in Texas, USA)
TEAM SIZE
101-250
COMPANY MISSION
Building the world's most comprehensive self-quantification platform that creates a grand unified view of the human body through integrated biomarker tracking